ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,112.49
0.25%
US Tech 100
17,298.00
0.34%
Dow Jones
38,350.92
0.29%
Brent Oil
87.415
-0.30%
Bitcoin
62,945.35
-0.09%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Quote

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
0.753
-0.047
(-5.88%)
Closed April 29 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.753
Bid
0.75
Ask
0.769
Volume
425,381
0.751 Day's Range 0.81
0.41 52 Week Range 19.56
Market Cap
-
Previous Close
0.80
Open
0.805
Last Trade
140
@
0.753
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
765,752
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
1970
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 0.80 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.41 € to 19.56 €.

Vivoryon Therapeut currently has 0 shares outstanding.

VVY Latest News

More News

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and...

April 24 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024 Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and...

April 16 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Announces Changes to Board Composition

Vivoryon Therapeutics N.V. Announces Changes to Board Composition Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon...

March 15 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease   Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of...

March 04 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Halle (Saale) / Munich, Germany, January 8, 2024 –...

January 08 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and...

December 06 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational...

November 28 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Halle (Saale) / Munich, Germany, November 7, 2023 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7...

November 07 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision

Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision Vivoryon Therapeutics...

October 26 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Positive Outcome from Independent Data Safety Monitoring Board with Unanimous Decision for VIVA-MIND U.S. Study of Varoglutamstat in Alzheimer’s Disease to Proceed at Highest Investigated Dose

Vivoryon Therapeutics N.V. Reports Positive Outcome from Independent Data Safety Monitoring Board with Unanimous Decision for VIVA-MIND U.S. Study of Varoglutamstat in Alzheimer’s Disease to...

October 23 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.28360.21276595740.470.9990.4516772620.80183056DE
40.21339.44444444440.540.9990.415724630.72969993DE
12-7.727-91.12028301898.489.930.417657521.02078DE
26-6.807-90.03968253977.569.930.413927551.69398871DE
52-12.747-94.422222222213.519.560.412296263.4768114DE
156-14.127-94.93951612914.8823.250.411189576.79672641DE
260-4.837-86.52951699465.5923.250.411058767.2123231DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAUDCollective Audience Inc
$ 0.7327
(87.87%)
139.03M
DCPHDeciphera Pharmaceuticals Inc
$ 25.285
(72.59%)
39.68M
MULNMullen Automotive Inc
$ 4.47
(41.46%)
33.65M
HWHHWH International Inc
$ 2.52
(38.46%)
23.06M
BTOGBit Origin Ltd
$ 4.46
(34.34%)
396.42k
CLVRClever Leaves Holdings Inc
$ 1.59
(-61.31%)
615.22k
ADXNAddex Therapeutics Ltd
$ 8.00
(-50.31%)
123.03k
MFImF International Ltd
$ 1.5294
(-34.36%)
2.52M
TSDDGraniteShares ETF Trust GraniteShares
$ 17.00
(-31.73%)
1.16M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 26.88
(-31.55%)
5.82M
TSLATesla Inc
$ 194.94
(15.84%)
163.83M
CAUDCollective Audience Inc
$ 0.7327
(87.87%)
139.03M
SINTSiNtx Technologies Inc
$ 0.0527
(30.45%)
138.53M
SOFISoFi Technologies Inc
$ 7.0899
(-9.91%)
112.19M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.42
(31.75%)
63.74M

Discussion

View Full Feed
monocle monocle 3 minutes ago
Isn't 75% of the niobium spoken for through off takes with foreign companies? Stellantis is a foreign company as well.
NB
don estaban don estaban 3 minutes ago
Agree 100% with you this Nov. Will have nothing to do with MV's success or failure
MVNT
JFR161162 JFR161162 3 minutes ago
I didn’t say in the USA.
What I said is the decision is in the hands of the MHRA & the politics will fit it in their agenda when it’s time to make it public.

DCVAX QILL BE APPROVED.
No question about that.

Those who don’t understand politics won’t agree w
NWBO
Monksdream Monksdream 3 minutes ago
IBIO under $2
https://investorshub.advfn.com/uimage/uploads/2024/4/29/dksknIMG_7839.gif
IBIO
rbtree rbtree 3 minutes ago
You have no proof that KEGS was ever shorted at any price.

Might as well keep in character with the BS, eh?

Sigh.........
KEGS
Theo Theo 3 minutes ago
They couldn't let a deal like this pass them by 😉

(I did get some OCT (otm) Calls today prior though 😀)
ATOM
knrorrel knrorrel 3 minutes ago
News and JAGX boooooming 1000% - lol
all only imho
JAGX
gawti88 gawti88 3 minutes ago
Yah, im super happy at the progress they're growing at!
CEOS
pos_stock_hoarder pos_stock_hoarder 4 minutes ago
Speaking of covers today, they sure did well with this Hoyt Axton song! Jerimiah was another.
JMCK6193 JMCK6193 4 minutes ago
Huh?
SING
4u2nv2 4u2nv2 4 minutes ago
Not really, just rounding off to the the next even hundreds of millions in one of my accounts. :)
MCIC
zakattack zakattack 4 minutes ago
This stock proves you can loses every single day and never improve
GNCP
Pyramid2 Pyramid2 4 minutes ago
$TSLA target $206 for me here
TSLA
PennyMillions852 PennyMillions852 4 minutes ago
They have nothing better to do, any lack of movement here, they thrive on those ops to bash but hey....I guess they think stocks go up in a straight line! Heavy loading here and bashers are probably bid sitting to recoup their losses! This WILL break outta trips and they will still look to bash!
CBIA
knrorrel knrorrel 4 minutes ago
I dream where JAGX ends today, maybe over 0.30+++
JAGX
Spuds McKenz66 Spuds McKenz66 4 minutes ago
I agree with u 110% , I will take a hit 2k under water right now, watching SQQQ
SQQQ
ChannelTrader ChannelTrader 4 minutes ago
We may be the last old farts standing bro.
monocle monocle 4 minutes ago
Wholeheartedly agree with your last sentence and don't forget they got their biggest ever haul of cheap as hell options as well. Unforgivable imo.

Didn't Mark have performance based compensation at Largo rather than a straight-up salary?
NB
MasstrichtMan MasstrichtMan 5 minutes ago
Beyond the full page in NB's presentation celebrating that they applied for a loan (wee!); one thing that I never see discussed here is that EXIM, the entity upon which 99% of NB's hopes are now pegged, is in place to facilitate and encourage exports, but all the arguments (like the ones AO just pos
NB
I-Glow I-Glow 5 minutes ago
What happened to the big name change?

"TheIrishIntelligence
Thursday, 12/28/2023 2:37:15 PM

Confirming $SPZI name change to JP 3E Holdings, Inc. See image below. New website: https://jp3eholdings.com

Recall that this is only a step one in the proce
SPZI
wisetoit wisetoit 5 minutes ago
I don’t short either
PSRU
NorthPeak22 NorthPeak22 5 minutes ago
Weird that they are not allowing downloads of the letters. All of the letters after Devon just lead to a "timed out" error page.
TGLO
Monksdream Monksdream 5 minutes ago
NKGN under $2
https://investorshub.advfn.com/uimage/uploads/2024/4/29/ttzaaIMG_7838.gif
NKGN
ShadowDiviner72 ShadowDiviner72 6 minutes ago
Imagine when FOMO starts kicking in
JAGX
gitreal gitreal 6 minutes ago
I'm not leaving without massive wealth

I guess you're stuck here forever. There are still a few posters on the CRGP and SRGE boards years after those scams ran their course.
CRGP

Your Recent History

EU
VVY
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved